atopic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Meet the diagnostic criteria for moderate to severe atopic dermatitis; 2) Age =18 and =75 years old gender is not limited; 3) Peak Pruritus Numerical Rating Scale (PP-NRS) score =4; 4) Voluntarily participate in this trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients who are in the acute onset of the disease and have erosions exudates and secondary infections; 2) Patients who have participated in other clinical studies in the past 3 months or are participating in other clinical studies; 3) Patients with severe haematological diseases (e.g. platelet count <50×109 /L) and other serious diseases that may affect operation and efficacy; 4) Current systematic use of glucocorticosteroids discontinued for less than 7 days; immunosuppressants (cyclosporine methotrexate tretinoin etc.) discontinued for less than 1 month; dulprevirizumab discontinued for less than 1 month JAK inhibitors discontinued for less than 2 weeks; 5) Women who are pregnant or breastfeeding; 6) Patients with a history of acupuncture treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCORAD; | — |
Secondary
| Measure | Time frame |
|---|---|
| neuECG;Serum total IgE;POEM;DLQI;Peripheral blood serum cytokines;PP-NRS; | — |
Countries
China
Contacts
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine